The Deal
Essentially we give up to 70% of an asset. ie lose control of the Asset i
DDD may retain 30% or more and then give Shareholders the (so called) owners of the Asset 1share/10000 (approx) DDD owned shares
Only People already aligned with RM Finance will have access to buy IPO Shares and they need to be Sophiticated Investors.
Directors will now gain another Celery (and gift themselves Performance Shares Options etc in the new Company) Cynical but true.
The Majority of this New Company will be owned therefore controlled by Sophs who invest $4.5m for a premium asset we currently own.
Personally prefer DDD to retain 51% ownership at this point and will vote against it.
Convince me otherwise
Questions
#1 When definite Statements on what ShareHolders will get and which Shareholders?.
#2 How much Ownership will DDD retain in the new CO going forward after giving Current Shareholders new Co Shares?
Idea:
DDD take Royalties as % of the Deal and pay them direct to shareholders in the Future.
Become a Royalty Company with the Shareholders the Direct Benefactors not the Directors
- Forums
- ASX - By Stock
- Ann: IPO of Cosmo Newbery Gold Project
The DealEssentially we give up to 70% of an asset. ie lose...
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADG (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.589M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $2.927K | 585.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49702 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 6286004 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49702 | 0.005 |
18 | 13567577 | 0.004 |
33 | 16407548 | 0.003 |
11 | 68960000 | 0.002 |
11 | 69055001 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 6286004 | 10 |
0.007 | 9186635 | 5 |
0.008 | 5833333 | 5 |
0.009 | 5194444 | 4 |
0.010 | 4588410 | 7 |
Last trade - 15.33pm 12/11/2024 (20 minute delay) ? |
Featured News
ADG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online